Clinical data, regulatory milestones, AI-assisted discovery platforms, and expanding development pipelines are creating a steady stream of catalysts that investors will be watching closely during the ...
ASMED Clinic announced the integration of KE-Bot, a U.S.-patented, AI-powered robotic scanning system developed under the leadership of Dr. Koray Erdoğan, into its clinical workflow to enhance ...
Two innovative, forward-thinking organizations show how rebuilding patient trust is becoming the real breakthrough driving ...
Morning Overview on MSN
One breach this month exposed clinical-trial patients’ IDs and health data
Clinical-trial patients whose records were stored on a CareCloud electronic health-record system now face an open question ...
Well before the term “personalized medicine” first appeared, the notion of healthcare tailored to the individual loomed on ...
Samsung and Alcedis will explore how Galaxy Watch biometric data can support clinical trials, digital endpoints, and drug ...
Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag of clinical AI, digital health at the FDA, and the boom in direct-to-consumer ...
New Evidence Further Defines Distinct Clinical Considerations for Transcatheter Aortic Valve Replacement (TAVR) in Aortic Regurgitation (AR) and Advances Understanding of the Trilogy® System in Patien ...
Nearly 30% of the data collected in clinical trials do not directly inform key decisions, yet patients are still asked to ...
Asianet Newsable on MSN
TGTX stock continues rally for 8 straight sessions on new BRIUMVI clinical data
Recent announcements from TG Therapeutics have buoyed optimism on the long-term potential of its Briumvi drug.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results